Main Summit Day One: Tuesday, February 15, 2011

7:15 Registration & Coffee

8:00 Welcome And Opening Remarks

Sponsored By Clean Earth Technologies

8:10Keynote: NCB CBRN Program & Portfolio

  • Overview of the US nuclear weapons program and how it affects the industry and the public
  • Identification of specific issues regarding nuclear threats
  • Current initiatives and future goals to counter nuclear threats

Steve Henry, SES
Deputy Assistant to the Secretary of Defense for Nuclear Matters
(DATSD/NM)

8:50 FDA Pandemic Task Force: FDA’s Medical Countermeasures Initiative

  • Overview of the US government involvement in MCM development (post 9/11)
  • The mission and overview of the HHS/PHEMCE Model
  • The Medical Countermeasures Initiative: Pillars I, II and III defined and the road ahead for MCM development

Dr. Alan Liss
Director, MCMi PHSAT
Office of Counterterrorism and Emerging Threats (OCET) OCS/OC/FDA

9:30 The Future Direction For Combating Pandemic Flu And CBRN Threats

  • Response to pandemic flu
  • Lessons learned
  • The way forward for public health emergencies and CBRN agents

Dr. Robin A. Robinson
Director & Deputy Assistant Secretary
HHS/ASPR/BARDA

10:10 Networking & Refreshment Break

10:55 CBRN Medical Countermeasure Development: Novel Approaches Developed By BARDA

  • HHS roles and responsibilities in CBRN medical preparedness and response
  • Current and future BARDA CBRN medical countermeasures programs
  • The Integrated National Biodefense CBRN medical countermeasures portfolio

Dr. Gerald Kovacs
Director, Division of CBRN Countermeasures Biomedical
Advanced Research and Development Authority (BARDA), U.S.
Dept. of Health and Human Services

11:35 DHS’s Early Detection Biodefense Programs

  • Integrating bio-monitoring activities of executive branch departments including: biosurveillance, aersosol detection, environmental animal surveillance, clinical syndrome detection, mail room observation and suspicious substance management
  • Advancing the effectiveness of Project BioShield
  • Incorporating S&T’s research and development for improved technology for greater detection and cost efficiency
  • Expediting support to limit suffering and illness in the event of a catastrophic chemical attack
  • Providing leadership and direction to assist in the nation’s preparedness against a chemical attack and ensure the execution of an effective response

Robert Hooks
Deputy Assistant Secretary for WMD and Biodefense, Office of Health Affairs
Department of Homeland Security

12:15 Lunch

1:20 Medicine To Millions: The Challenges Of Dispensing Medical Countermeasures To Civilian Populations Following A Catastrophic Event

  • Historical perspectives in mass dispensing chemotherapeutics to civilian populations
  • The current medical-public health architecture - gains from a decade of preparedness
  • Challenges to mass dispensing; product, population, legal, regulatory and other
  • Medical countermeasures, US health security, and the path ahead

Dr. Elin Gursky
Senior Advisor at U.S. Dept. of Health and Human Services

2:00 Improving The Nation’s Response And Recovery: FEMA’s Role In CBRNE Incident Preparedness And Response

  • Improving the nation’s response and recovery of CBRNE catastrophic events
  • Planning for and integrating CBRNE unique response and recovery activities within emerging support functions

Chad Gorman
CBRNE Branch Manager, Federal Emergency Management
Agency HQ Response Directorate

2:40 C/B Decon Technologies as Force Multipliers

  • Science background for decontamination technology
  • The context in which C/B decontamination is conducted
  • How decontamination operational practice affects capabilities and resource utilization
  • Implications for preparedness and outcomes

Dr. Jeffry Golden
Co-Founder and Managing Member, CET, LLC

3:20 Networking & Refreshment Break

4:00 Updates On The US National Vaccine Plan

  • Providing framework, goals, objectives, and strategies, for pursuing the prevention of infectious diseases through immunizations
  • Evolving issues and challenges
  • Strategy for enhancing vaccine research and development, vaccine safety, informed decision making by providers and the public, coverage and supply and global health

Raymond A. Strikas M.D., FACP
CAPT, U.S. Public Health Service
National Vaccine Program Office
Department of Health and Human Services

4:40 Live Agent Training at Counter Terrorism Technology Centre (CTTC)

  • Mission and Mandate
  • CWA (Nerve and Blister), bio and radiological training,
  • Laboratory Facilities and Cameron Centre Training Facility;
  • Enhanced technical rescue and Improvised Explosive Devices (IED’s), Improvised Dispersal Devices (IDD’s)

Wil Herdman
CD, Training Officer, Training Section, Defence Research and Development
Canada

5:20 Pandemic Preparedness and Lessons Learned from H1N1

  • Challenges anticipated in monitoring the safety of the 2009-2010 H1N1 influenza vaccine
  • Adaptation of existing safety monitoring systems and development of new systems for the 2009-2010 H1N1 influenza vaccine
  • Lessons learned from monitoring the safety of the 2009-2010 H1N1 influenza vaccine

Dr. Daniel Salmon
Director of Vaccine Safety, National Vaccine Program Office
U.S. Department of Health and Human Services

6:00 End Of Day One

[ Register Now ]